- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Advocate Discusses Misconceptions, Culturally Sensitive Care for Hidradenitis Suppurativa
Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), spoke on common stigmas regarding HS and how clinicians can improve consultation through a culturally sensitive approach.
There are several misconceptions regarding hidradenitis suppurativa (HS) that clinicians should address with a culturally sensitive approach, said Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with HS.
Transcript
Can you speak on misconceptions in the management of HS?
We understand fully that cigarette smoking and weight loss are very important topics. Cigarette smoking can kill you—it's been proven, it's very bad for you—and being overweight is indicative of being unhealthy and we get that, too. If I meet a doctor, and in the first 30 minutes, they tell me that I need to quit smoking and lose weight, I kind of tune them out.
We are working, as the patient community, to kind of help doctors understand that we have organized online and we know a lot of patients who are thin that have this disease. There are patients who have anorexia that have this disease. And again, I'm not saying that we shouldn't be trying to incorporate a healthy diet into our lifestyle, that smoking isn't horrible for you—it absolutely is—but maybe that can be a nudge in the second or third appointment and done gently.
This reputation that patients with HS have that we’re overweight smokers only leads into more of this stigma that we are doing this to ourselves. If it were as simple as that we would do this, but it's a little more complex than that.
Public Hospitals More Likely to Extend Unprofitable Services After 340B Participation, Study Finds
May 10th 2024Public hospitals were significantly more likely to sustain access to unprofitable services following 340B Drug Pricing Program participation, while nonprofit hospitals were mostly unaffected, according to a recent study.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Persistence Pays Off With Zanubrutinib: A Challenging CLL Case With a Prior BTK Inhibitor Failure
May 10th 2024The case of a 77-year-old woman with a long chronic lymphocytic leukemia (CLL) history illustrates the novel use of zanubrutinib as a potential option for some patients who have failed first-generation Bruton tyrosine kinase (BTK) inhibitors and venetoclax.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
